4,4'-Di-O-methylellagic acid

4,4'-Di-O-methylellagic acid
Product Name 4,4'-Di-O-methylellagic acid
CAS No.: 3374-77-4
Catalog No.: CFN92805
Molecular Formula: C16H10O8
Molecular Weight: 330.0 g/mol
Purity: >=98%
Type of Compound: Phenols
Physical Desc.: Powder
Targets: Wnt/β-catenin
Source: The peels of Punica granatum L.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price:
4,4'-di-O-methylellagic acid is the most effective compound in the inhibition of colon cancer cell proliferation.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • J Chromatogr B Analyt Technol Biomed Life Sci.2019, 1113:1-13
  • Key Engineering Materials2022, 931(47-53).
  • Talanta Open2023, 7:100227
  • Nat Commun.2019, 10(1):2745
  • J Ethnopharmacol.2019, 244:112074
  • Turk J Med Sci.2023 53: 1312-1320.
  • Korean Herb. Med. Inf.2020, 8(2):243-254.
  • Sci Rep.2019, 9(1):4646
  • PLoS One.2018, 13(4):e0195642
  • J Chromatogr A.2017, 1518:46-58
  • Punicalin

    Catalog No: CFN98113
    CAS No: 65995-64-4
    Price: $218/20mg
    Punicalagin

    Catalog No: CFN99938
    CAS No: 65995-63-3
    Price: $108/20mg
    Terchebulin

    Catalog No: CFN92297
    CAS No: 132854-40-1
    Price: Inquiry(manager@chemfaces.com)
    Ellagic acid-4-O-beta-D-xylopyranoside

    Catalog No: CFN95618
    CAS No: 139163-18-1
    Price: $318/5mg
    Ellagic acid 4-O-alpha-L-arabinofuranoside

    Catalog No: CFN95613
    CAS No: 358617-39-7
    Price: $318/5mg
    Eschweilenol C

    Catalog No: CFN95363
    CAS No: 211371-02-7
    Price: $318/10mg
    Ellagic acid glucoside

    Catalog No: CFN95878
    CAS No: 163774-64-9
    Price: $318/5mg
    3-Methyl ellagic acid

    Catalog No: CFN70390
    CAS No: 51768-38-8
    Price: Inquiry(manager@chemfaces.com)
    Ducheside A

    Catalog No: CFN99833
    CAS No: 176665-78-4
    Price: Inquiry(manager@chemfaces.com)
    3-O-methylellagic acid 4'-O-alpha-L-rhamnopyranoside

    Catalog No: CFN95228
    CAS No: 51768-39-9
    Price: $413/5mg
    J Pharmacol Exp Ther. 2015 May;353(2):433-44.
    The ellagic acid derivative 4,4'-di-O-methylellagic acid efficiently inhibits colon cancer cell growth through a mechanism involving WNT16.[Pubmed: 25758919]
    Ellagic acid (EA) and some derivatives have been reported to inhibit cancer cell proliferation, induce cell cycle arrest, and modulate some important cellular processes related to cancer. This study aimed to identify possible structure-activity relationships of EA and some in vivo derivatives in their antiproliferative effect on both human colon cancer and normal cells, and to compare this activity with that of other polyphenols.
    METHODS AND RESULTS:
    Our results showed that 4,4'-Di-O-methylellagic acid (4,4'-DiOMEA) was the most effective compound in the inhibition of colon cancer cell proliferation. 4,4'-DiOMEA was 13-fold more effective than other compounds of the same family. In addition, 4,4'-DiOMEA was very active against colon cancer cells resistant to the chemotherapeutic agent 5-fluoracil, whereas no effect was observed in nonmalignant colon cells. Moreover, no correlation between antiproliferative and antioxidant activities was found, further supporting that structure differences might result in dissimilar molecular targets involved in their differential effects. Finally, microarray analysis revealed that 4,4'-DiOMEA modulated Wnt signaling, which might be involved in the potential antitumor action of this compound.
    CONCLUSIONS:
    Our results suggest that structural-activity differences between EA and 4,4'-DiOMEA might constitute the basis for a new strategy in anticancer drug discovery based on these chemical modifications.
    Apterin

    Catalog No: CFN95005
    CAS No: 53947-89-0
    Price: $388/10mg
    2'-Rhamnoechinacoside

    Catalog No: CFN95035
    CAS No: 1422390-59-7
    Price: $368/10mg
    Cyclocurcumin

    Catalog No: CFN95103
    CAS No: 153127-42-5
    Price: $338/10mg
    Epischisandrone

    Catalog No: CFN95212
    CAS No: 98619-26-2
    Price: $413/5mg
    Nortrachelogenin-5'-C-beta-glucoside

    Catalog No: CFN95251
    CAS No: 858127-39-6
    Price: $318/10mg
    New compound 11

    Catalog No: CFN95351
    CAS No: N/A
    Price: $318/10mg
    Quercetin 3,7-diglucoside

    Catalog No: CFN95408
    CAS No: 6892-74-6
    Price: $318/10mg
    Naringenin 7-O-gentiobioside

    Catalog No: CFN95435
    CAS No: 104154-33-8
    Price: $368/5mg
    Giganteone A

    Catalog No: CFN95481
    CAS No: 460337-13-7
    Price: $318/5mg
    Ganoderic acid GS-2

    Catalog No: CFN95549
    CAS No: 1206781-65-8
    Price: $413/5mg